Complementary TherapiesNCT04884321
Complementary And Alternative Medicine During The COVID-19 Pandemic
An observational study of Complementary Therapies, run by Hasan Kalyoncu University at 1 site in Turkey (Türkiye).
Trial summary
Complementary and alternative medicine is frequently used in the treatment of several groups of diseases. Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Complementary Therapies
- What is being tested?
- Complementary And Alternative Medicine
- How many people
- 3,242 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 27 Feb 2021to 30 Mar 2021
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Adult, Older adult
Study population: The research population was comprised of Turkish citizens who resided in Turkey and were aged 18-65 years.
Who may be able to join
- agree to participate in the study
- not to be a communication problem
Who cannot join
- be a communication problem
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Hasan Kalyoncu Ünivrsitesi
Gaziantep, Lütfen Seç, 27000
About this study
Official title: Adults' Attitudes Toward Complementary And Alternative Medicine And Their State Of Using Complementary And Alternative Medicine During The COVID-19 Pandemic
Complementary and alternative medicine is frequently used in the treatment of several groups of diseases.
Read the detailed description
This study aimed to explore the attitudes of adults living in Turkey toward complementary and alternative medicine in the period of the COVID-19 pandemic and identify whether Turkish adults used it during the pandemic.
- Conditions
- Complementary Therapies
- Being tested
- Complementary And Alternative Medicine
- Keywords
- Complementary Therapies, COVID-19, Complementary and Alternative Medicine, Attitude
- Medical subject headings
- COVID-19, Behavior
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Complementary And Alternative MedicineOther
No intervention was done in the cross-sectional study
What is being measured
The primary outcome is the main question the study is designed to answer.
Participant adults' responses to the questions raised about the use of complementary and alternative methods during the COVID-19 pandemic
Measured: 2021
Means of scores obtained by participant adults from the holistic complementary and alternative medicine questionnaire (HCAMQ) and its sub-scales
Holistic Complementary and Alternative Medicine Questionnaire
Measured: 2021
Complementary and alternative treatment methods used during the COVID-19 pandemic
Measured: 2021
Plants consumed during the COVID-19 pandemic
Measured: 2021
Symptoms against which complementary and alternative methods are used during the COVID-19 pandemic
Measured: 2021
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 May 2021
- Study start27 Feb 2021
- Primary completion30 Mar 2021
- Study completion30 Mar 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Complementary TherapiesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Other
- Enrolment
- 3,242 participants (actual)
Sponsor and investigators
- Lead sponsor
- Hasan Kalyoncu University
- Sponsor type
- University, hospital or other
- Collaborators
- Filiz Polat, Aynur Ekren Çakıcı
- Responsible party
- Principal investigator, Leyla Delibas, Hasan Kalyoncu University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04884321
- Sponsor's protocol ID
- HasanKUMYO
- Status last verified
- May 2021
- First submitted
- 7 May 2021
- Last updated
- 12 May 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 12 May 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Adults' Attitudes Toward Complementary And Alternative Medicine And Their State Of Using Complementary And Alternative Medicine During The COVID-19 Pandemic
- ClinicalTrials.gov ID
- NCT04884321
- Acronym / sponsor ID
- HasanKUMYO
- Conditions
- Complementary Therapies
- Keywords
- Complementary Therapies, COVID-19, Complementary and Alternative Medicine, Attitude
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 3,242 participants (actual)
- Lead sponsor
- Hasan Kalyoncu UniversityUniversity, hospital or other
- Collaborators
- Filiz Polat, Aynur Ekren Çakıcı
- Study start
- 27 Feb 2021 (actual)
- Primary completion
- 30 Mar 2021 (actual)
- Study completion
- 30 Mar 2021 (actual)
- First posted
- 12 May 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Complementary and alternative medicine is frequently used in the treatment of several groups of diseases.
Detailed description
This study aimed to explore the attitudes of adults living in Turkey toward complementary and alternative medicine in the period of the COVID-19 pandemic and identify whether Turkish adults used it during the pandemic.
Study design
- Observational model
- Other
- Time perspective
- Other
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- The research population was comprised of Turkish citizens who resided in Turkey and were aged 18-65 years.
Key inclusion criteria (2 listed)
- agree to participate in the study
- not to be a communication problem
Key exclusion criteria (1 listed)
- be a communication problem
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Complementary And Alternative MedicineNo intervention was done in the cross-sectional study | Other | – |
Primary outcome
Participant adults' responses to the questions raised about the use of complementary and alternative methods during the COVID-19 pandemic
Time frame: 2021
Means of scores obtained by participant adults from the holistic complementary and alternative medicine questionnaire (HCAMQ) and its sub-scales
Time frame: 2021
Holistic Complementary and Alternative Medicine Questionnaire
Complementary and alternative treatment methods used during the COVID-19 pandemic
Time frame: 2021
Plants consumed during the COVID-19 pandemic
Time frame: 2021
Symptoms against which complementary and alternative methods are used during the COVID-19 pandemic
Time frame: 2021
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 May 2021.
- Individual participant dataSharing planned: Undecided
Related trials for Complementary Therapies
Not yet recruiting
Effects of Paraffin Wax Therapy and Dry Cupping on Pain and Wrist Function in Patients With Rheumatoid Arthritis
Rheumatic Arthritis
Not yet recruiting
Effects of Horticultural Therapy on Acute Stress and Salivary Cortisol Levels in Hemodialysis Patients
End-Stage Renal Disease, Renal Dialysis
Not yet recruitingPhase 3
Veterans' Intervention Blending NeuRomodulation and YogA for Chronic Low BackPaiN Treatment: VIBRANT
Chronic Low Back Pain, Musculoskeletal Pain
Recruiting
Acupressure as Complementary Analgesia in Shock Wave Lithotripsy
Acupressure, Urinary Calculi
Not yet recruiting
Foot Reflexology for Anxiety in Women Hospitalized With High-Risk Pregnancy
Anxiety, Pregnancy, High-Risk
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Complementary Therapies, run by Hasan Kalyoncu University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 12 May 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Participant adults' responses to the questions raised about the use of complementary and alternative methods during the COVID-19 pandemic (time frame: 2021). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 May 2021.